Invention Grant
- Patent Title: Antagonist antibodies against EphB3
- Patent Title (中): 抗EphB3抗体抗体
-
Application No.: US14592115Application Date: 2015-01-08
-
Publication No.: US09541004B2Publication Date: 2017-01-10
- Inventor: Linda Masat , Jeff Hsu
- Applicant: NOVARTIS AG , XOMA TECHNOLOGY LTD.
- Applicant Address: CH Basel US CA Berkeley
- Assignee: NOVARTIS AG,XOMA TECHNOLOGY LTD.
- Current Assignee: NOVARTIS AG,XOMA TECHNOLOGY LTD.
- Current Assignee Address: CH Basel US CA Berkeley
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C07K16/28 ; C12P21/08 ; F02C7/20 ; F02K1/80 ; F02K3/10 ; F16B35/04 ; F01D25/16 ; F16B33/00 ; F16B43/00
Abstract:
EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating an EphB3-related disease or disorder.
Public/Granted literature
- US20150183872A1 ANTAGONIST ANTIBODIES AGAINST EPHB3 Public/Granted day:2015-07-02
Information query
